Phase II Clinical Trial to Study the Feasibility and Safety of the Expanded Autologous Stem Cells Use Derived From Adipose Tissue (e-ASC) for the Local Urinary Incontinence After a Radical Prostate Cancer Surgery
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Evaluate the feasibility and security of the autologous e-ASC for the urinary incontinence after a radical prostate cancer surgery
Possibility of inject ASc by cystoscope
16 weeks
No
Sergio Alonso Gregorio, MD
Principal Investigator
Cell Therapy laboratory and general Surgery Department, Hospital Universitario La Paz
Spain: Spanish Agency of Medicines
FLPURO-2009-01
NCT01799694
July 2011
February 2013
Name | Location |
---|